Abstract
With the epidemiology now well described, stroke has been uncovered as a frequent cause of neurological disease in children. Arterial ischemic stroke (AIS) is the most common type, affecting both neonates and older children. The number of associated risk factors is large with current efforts directed toward understanding the mechanisms by which they translate into a stroke. Advanced neuroimaging modalities are improving diagnostic accuracy while affording unique avenues to explore the pathophysiology of stroke and the response of the developing brain to injury. While acute interventions for pediatric stroke are in their infancy, the first randomized controlled clinical trials for the initial management and secondary prevention of pediatric stroke are poised to begin. Outcomes from childhood stroke are well defined though the accurate predictors required to guide treatment and rehabilitation remain elusive. We review the essential background, recent advances, and current clinical research issues pertaining to AIS in children.
Keywords: Pediatric stroke, arterial ischemic stroke, cerebrovascular disease, child
Current Pediatric Reviews
Title: Arterial Ischemic Stroke in Neonates and Children: Review and Current Issues
Volume: 2 Issue: 4
Author(s): Adam Kirton, Michael D. Hill and Gabrielle deVeber
Affiliation:
Keywords: Pediatric stroke, arterial ischemic stroke, cerebrovascular disease, child
Abstract: With the epidemiology now well described, stroke has been uncovered as a frequent cause of neurological disease in children. Arterial ischemic stroke (AIS) is the most common type, affecting both neonates and older children. The number of associated risk factors is large with current efforts directed toward understanding the mechanisms by which they translate into a stroke. Advanced neuroimaging modalities are improving diagnostic accuracy while affording unique avenues to explore the pathophysiology of stroke and the response of the developing brain to injury. While acute interventions for pediatric stroke are in their infancy, the first randomized controlled clinical trials for the initial management and secondary prevention of pediatric stroke are poised to begin. Outcomes from childhood stroke are well defined though the accurate predictors required to guide treatment and rehabilitation remain elusive. We review the essential background, recent advances, and current clinical research issues pertaining to AIS in children.
Export Options
About this article
Cite this article as:
Kirton Adam, Hill D. Michael and deVeber Gabrielle, Arterial Ischemic Stroke in Neonates and Children: Review and Current Issues, Current Pediatric Reviews 2006; 2 (4) . https://dx.doi.org/10.2174/157339606778699635
| DOI https://dx.doi.org/10.2174/157339606778699635 |
Print ISSN 1573-3963 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
Call for Papers in Thematic Issues
Early-Life Nutrition: Impacts on Health and Diseases
In early life, organs and hormonal axes are especially susceptible to changes that can affect the intestinal mucosa, immune system, and long-term health. Critical factors in the developmental process, including maternal diet, type of delivery, breastfeeding, and the nutritional status of mothers and children, have gained prominence. Evidence suggests that ...read more
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cell Biological Consequences of Mitochondrial NADH: Ubiquinone Oxidoreductase Deficiency
Current Neurovascular Research The Role of Matrix Metalloproteinases in Diabetes Mellitus
Current Topics in Medicinal Chemistry The Emerging Role of COX-2, 15-LOX and PPARγ in Metabolic Diseases and Cancer: An Introduction to Novel Multi-target Directed Ligands (MTDLs)
Current Medicinal Chemistry The Biological and Clinical Activity of Anti-Malarial Drugs In Autoimmune Disorders
Current Rheumatology Reviews A Practical Comprehensive Approach to Management of Acute Decompensated Heart Failure
Current Cardiology Reviews Pharmacokinetics of Antifungal Agents in Neonates and Young Infants
Current Medicinal Chemistry Protein PDK4 Interacts with HMGCS2 to Facilitate High Glucoseinduced Myocardial Injuries
Current Molecular Medicine Oxidative Biotransformation of Fatty Acids by Cytochromes P450: Predicted Key Structural Elements Orchestrating Substrate Specificity, Regioselectivity and Catalytic Efficiency
Current Drug Metabolism Preclinical Development of New Therapy for Glycogen Storage Diseases
Current Gene Therapy Pathophysiology of Cardiovascular Diseases and the Role of Vitamins, and Herbal Extracts in the Reduction of Cardiovascular Risks
Cardiovascular & Hematological Agents in Medicinal Chemistry Common Genetic Conditions of Ischemic Stroke to Keep in Mind
Current Molecular Medicine The Effect of CB1 Antagonism on Hepatic Oxidative/Nitrosative Stress and Inflammation in Nonalcoholic Fatty Liver Disease
Current Medicinal Chemistry Complex Inheritance for Susceptibility to Sudden Cardiac Death
Current Pharmaceutical Design Artificial Intelligence for Epigenetics: Towards Personalized Medicine
Current Medicinal Chemistry Biomarkers in Hypertension and Hypertension-related Disorders
Current Medicinal Chemistry Coinhibitory Molecule PD-1 as a Therapeutic Target in the Microenvironment of Multiple Myeloma
Current Cancer Drug Targets Apelin in the Control of Body Fluid Homeostasis and Cardiovascular Functions
Current Pharmaceutical Design Update on the Adverse Effects of Clozapine: Focus on Myocarditis
Current Drug Safety Association of Oxidative Stress to the Genesis of Anxiety: Implications for Possible Therapeutic Interventions
Current Neuropharmacology Personalised Genetic Intervention for Duchenne Muscular Dystrophy: Antisense Oligomers and Exon Skipping
Current Molecular Pharmacology





